ccc-flow

Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice

Goal: We sought to evaluate the security and tolerability of three calcitonin gene-related peptide (CGRP) monoclonal antibodies in sufferers with continual migraine who have failed a number of lessons of migraine preventive therapies.

Background: CGRP is a crucial neuromodulator implicated within the pathogenesis of migraine. They’re accepted for the remedy of episodic and continual migraine. In present medical apply, CGRP monoclonal antibodies are utilized in sufferers who’ve failed a number of preventive brokers, however security, tolerability, and efficacy haven’t been properly described in real-world populations outdoors of medical trials.

Strategies: This was a single-center, observational, retrospective research in adults with continual migraine handled with a CGRP monoclonal antibody between Could 1, 2018 and September 30, 2019. Charts have been reviewed at 0, 3, and 6 months after remedy.

Outcomes: From Could 1, 2018 to September 30, 2019, 77 sufferers with continual migraine have been prescribed 90 remedy trials of a CGRP monoclonal antibody. Sufferers reported antagonistic outcomes in 2/5 (40.0%) with erenumab 70 mg, 32/46 (69.6%) with erenumab 140 mg, 8/16 (50.0%) with fremanezumab, and 15/23 (65.2%) with galcanezumab. Probably the most frequent antagonistic results have been constipation and injection website reactions.

Adversarial results resulting in discontinuation have been reported as follows: erenumab 70 mg 1/5 (20.0%), erenumab 140 mg 10/46 (22.7%), fremanezumab 1/16 (6.3%), and galcanezumab 1/23 (4.3%), with 13/90 (14.4%) discontinuation price total. Probably the most frequent causes for discontinuation have been lack of enchancment in 17/90 (18.9%) and constipation in 4/90 (4.4%). A 50% or higher discount within the variety of extreme headache days monthly was achieved for 32/66 (48.5%) at Three months and 17/48 (35.4%) at 6 months.

Conclusions: In sufferers with continual migraine, the three CGRP monoclonal antibodies have been properly tolerated, and diminished the variety of extreme headache days.

Refractory short-lasting unilateral neuralgiform headache assaults with conjunctival injection and tearing aware of anti-calcitonin gene-related peptide monoclonal antibodies: A case report

Background: Quick-lasting unilateral neuralgiform headache assaults with conjunctival injection and tearing (SUNCT) is a uncommon however severely disabling variant throughout the spectrum of trigeminal autonomic cephalalgia missing evidence-based remedy.

 

Case: We report a case of continual SUNCT in a 67-year-old man refractory to varied guideline-conforming remedy makes an attempt responding excellently to galcanezumab.

 

Conclusions: This case report signifies that monoclonal antibodies towards calcitonin gene-related peptide, particularly galcanezumab, is perhaps a remedy possibility for SUNCT warranting additional investigation.

A minimal physiologically primarily based pharmacokinetic mannequin to characterize colon TNF suppression and remedy results of an anti-TNF monoclonal antibody in a mouse inflammatory bowel illness mannequin

 

Biotherapeutic medication towards tumor necrosis issue (TNF) are efficient therapies for average to extreme inflammatory bowel illness (IBD). Right here, we evaluated CNTO 5048, an antimurine TNF surrogate monoclonal antibody (mAb), in a CD45RBexcessive adoptive T cell switch mouse colitis mannequin, which permits examination of the early immunological occasions related to intestine irritation and the therapeutic results.

The research was designed to quantitatively perceive the consequences of IBD on CNTO 5048 disposition, the power of CNTO 5048 to neutralize pathogenic TNF on the colon beneath illness circumstances, and the affect of dosing routine on CNTO 5048 remedy impact. CNTO 5048 and TNF concentrations in each mice serum and colon homogenate have been additionally measured.

Free TNF concentrations in colon, however not in serum, have been proven to correlate properly with the colon pharmacodynamic readout, such because the summed histopathology rating and neutrophil rating. A minimal physiologically primarily based pharmacokinetic (mPBPK) mannequin was developed to characterize CNTO 5048 PK and disposition, in addition to colon soluble TNF goal engagement (TE).

The mPBPK/TE mannequin moderately captured the noticed knowledge and offered a quantitative understanding of an anti-TNF mAb on its colon TNF suppression and therapeutic impact in a physiologically related IBD animal mannequin.

These outcomes additionally offered insights into the potential advantages of utilizing induction doses for the remedy of IBD sufferers.

ccc-flow
ccc-flow

Exceptionally potent human monoclonal antibodies are efficient for prophylaxis and remedy of tetanus in mice

Human monoclonal antibodies have been used right here to review the mechanism of neuron intoxication by tetanus neurotoxin and to guage them as a protected preventive and therapeutic substitute of hyperimmune sera for tetanus in mice. By screening reminiscence B cells of immune donors, we chosen two monoclonal antibodies particular for tetanus neurotoxin with exceptionally excessive neutralizing actions, which have been extensively characterised each structurally and functionally. We discovered that these antibodies intervene with the binding and translocation of the neurotoxin into neurons by interacting with two epitopes, whose definition pinpoints essential occasions within the mobile pathogenesis of tetanus.
This info explains the unprecedented neutralization skill of those antibodies, which have been discovered to be exceptionally potent in stopping experimental tetanus when injected in mice lengthy earlier than the neurotoxin. Furthermore, their Fab derivatives neutralized tetanus neurotoxin in post-exposure experiments, suggesting their potential therapeutic use by way of intrathecal injection. As such, these human monoclonal antibodies, in addition to their Fab derivatives, meet all necessities for being thought-about for prophylaxis and remedy of human tetanus and are prepared for medical trials.

A Randomized Section II Research of Anti-CSF-1 Monoclonal Antibody Lacnotuzumab (MCS110) Mixed with Gemcitabine and Carboplatin in Superior Triple Damaging Breast Most cancers

Objective: This part II research decided the efficacy of lacnotuzumab added to gemcitabine plus carboplatin (gem-carbo) in sufferers with superior triple-negative breast most cancers (TNBC).
Experimental design: Feminine sufferers with superior TNBC, with excessive ranges of tumor-associated macrophages, and never amenable to healing remedy by surgical procedure or radiotherapy, have been enrolled. Lacnotuzumab was dosed at 10 mg/kg each Three weeks (Q3W), {plus minus} a dose on Cycle 1, Day 8. Gem and carbo got at 1000 mg/m2 and space beneath curve 2 dose in mg, respectively, Q3W. Therapy continued till unacceptable toxicity, illness development, or discontinuation by doctor/affected person.
Outcomes: Sufferers obtained lacnotuzumab+gem-carbo (n=34) or gem-carbo (n=15). Enrollment was halted as a result of recruitment challenges owing to fast evolution of the therapeutic panorama; formal speculation testing of the first endpoint, was due to this fact not carried out. Median progression-free survival was 5.6 months (90% CI: 4.47, 8.64) within the lacnotuzumab+gem-carbo arm and 5.5 months (90% CI: 3.45, 7.46) within the gem-carbo arm. Hematologic antagonistic occasions have been frequent in each remedy arms; nonetheless, sufferers handled with lacnotuzumab skilled extra frequent aspartate aminotransferase, alanine aminotransferase, and creatine kinase elevations. Pharmacokinetic outcomes confirmed that free lacnotuzumab at 10 mg/kg exhibited a typical IgG pharmacokinetic profile and goal engagement of circulating CSF-1 ligand.
Conclusions: Regardless of profitable goal engagement and anticipated pharmacokinetic profile, lacnotuzumab+gem-carbo confirmed comparable antitumor exercise to gem-carbo alone, with barely poorer tolerability. Nevertheless, the info offered on this manuscript can be informative for future research testing brokers concentrating on the CSF-1-CSF-1R pathway in TNBC.

Human Calprotectin (CALPRO) ELISA Kit

RDR-CALPRO-Hu-96Tests 96 Tests
EUR 756

Human Calprotectin (CALPRO) ELISA Kit

RD-CALPRO-Hu-48Tests 48 Tests
EUR 521

Human Calprotectin (CALPRO) ELISA Kit

RD-CALPRO-Hu-96Tests 96 Tests
EUR 723

Calprotectin (CALPRO) Monoclonal Antibody (Human)

4-MAK504Hu21
  • EUR 310.00
  • EUR 3500.00
  • EUR 850.00
  • EUR 400.00
  • EUR 241.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO)

Calprotectin (CALPRO) Antibody

20-abx132157
  • EUR 495.00
  • EUR 133.00
  • EUR 1497.00
  • EUR 704.00
  • EUR 398.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-12 working days.

Calprotectin (CALPRO) Antibody

20-abx132274
  • EUR 425.00
  • EUR 1094.00
  • EUR 537.00
  • EUR 154.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-12 working days.

Calprotectin (CALPRO) Monoclonal Antibody (Human), APC

4-MAK504Hu21-APC
  • EUR 440.00
  • EUR 4625.00
  • EUR 1250.00
  • EUR 575.00
  • EUR 260.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with APC.

Calprotectin (CALPRO) Monoclonal Antibody (Human), Biotinylated

4-MAK504Hu21-Biotin
  • EUR 381.00
  • EUR 3450.00
  • EUR 975.00
  • EUR 480.00
  • EUR 249.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with Biotin.

Calprotectin (CALPRO) Monoclonal Antibody (Human), Cy3

4-MAK504Hu21-Cy3
  • EUR 545.00
  • EUR 6125.00
  • EUR 1625.00
  • EUR 725.00
  • EUR 305.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with Cy3.

Calprotectin (CALPRO) Monoclonal Antibody (Human), FITC

4-MAK504Hu21-FITC
  • EUR 372.00
  • EUR 3720.00
  • EUR 1020.00
  • EUR 480.00
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with FITC.

Calprotectin (CALPRO) Monoclonal Antibody (Human), HRP

4-MAK504Hu21-HRP
  • EUR 398.00
  • EUR 4025.00
  • EUR 1100.00
  • EUR 515.00
  • EUR 242.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with HRP.

Calprotectin (CALPRO) Monoclonal Antibody (Human), PE

4-MAK504Hu21-PE
  • EUR 372.00
  • EUR 3720.00
  • EUR 1020.00
  • EUR 480.00
  • EUR 228.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with PE.

Mouse Calprotectin (CALPRO) Protein

20-abx167392
  • EUR 773.00
  • EUR 300.00
  • EUR 2444.00
  • EUR 926.00
  • EUR 551.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse)

4-PAK504Mu01
  • EUR 295.00
  • EUR 3275.00
  • EUR 799.00
  • EUR 379.00
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO)

Recombinant Calprotectin (CALPRO)

4-RPK504Hu01
  • EUR 535.46
  • EUR 246.00
  • EUR 1732.96
  • EUR 644.32
  • EUR 1188.64
  • EUR 421.00
  • EUR 4182.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: P05109
  • Buffer composition: 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 14/16kDa
  • Isoelectric Point: 6
Description: Recombinant Human Calprotectin expressed in: E.coli

Recombinant Calprotectin (CALPRO)

4-RPK504Mu01
  • EUR 556.96
  • EUR 252.00
  • EUR 1813.60
  • EUR 671.20
  • EUR 1242.40
  • EUR 436.00
  • EUR 4384.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Inquire
  • Buffer composition: 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): Inquire
  • Isoelectric Point: Inquire
Description: Recombinant Mouse Calprotectin expressed in: Prokaryotic expression

Calprotectin (CALPRO) Antibody Pair

20-abx370844
  • EUR 1748.00
  • EUR 1121.00
  • 10 × 96 tests
  • 5 × 96 tests
  • Shipped within 5-12 working days.

Calprotectin (CALPRO) Antibody (Biotin)

20-abx274560
  • EUR 453.00
  • EUR 217.00
  • EUR 1191.00
  • EUR 578.00
  • EUR 342.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-15 working days.

Calprotectin (CALPRO) Monoclonal Antibody (Human), APC-Cy7

4-MAK504Hu21-APC-Cy7
  • EUR 760.00
  • EUR 9130.00
  • EUR 2380.00
  • EUR 1030.00
  • EUR 400.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Mouse monoclonal antibody against Human Calprotectin (CALPRO). This antibody is labeled with APC-Cy7.

Mouse Calprotectin (CALPRO) ELISA Kit

abx257892-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

Mouse Calprotectin (CALPRO) ELISA Kit

20-abx585121
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Mouse Calprotectin (CALPRO) ELISA Kit

SEK504Mu-10x96wellstestplate 10x96-wells test plate
EUR 4862.4
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Mouse Calprotectin (CALPRO) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Calprotectin (CALPRO) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Calprotectin (CALPRO) ELISA Kit

SEK504Mu-1x48wellstestplate 1x48-wells test plate
EUR 488.08
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Mouse Calprotectin (CALPRO) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Calprotectin (CALPRO) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Calprotectin (CALPRO) ELISA Kit

SEK504Mu-1x96wellstestplate 1x96-wells test plate
EUR 654.4
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Mouse Calprotectin (CALPRO) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Calprotectin (CALPRO) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Calprotectin (CALPRO) ELISA Kit

SEK504Mu-5x96wellstestplate 5x96-wells test plate
EUR 2644.8
  • The Intra-assay Precision is determined when 3 samples with low, middle and high level of Mouse Calprotectin (CALPRO) were tested on 3 different plates, 8 replicates in each plate
  • CV(%) = SD/meanX100
  • Intra-Assay: CV<10%
  • Inter-Assay: CV<12%
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Calprotectin (CALPRO) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Mouse Calprotectin (CALPRO) ELISA Kit

4-SEK504Mu
  • EUR 4913.00
  • EUR 2595.00
  • EUR 655.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
  • Known also as Calprotectin elisa. Alternative names of the recognized antigen: MRP-8/MRP-14
  • S100A8/A9
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Calprotectin (CALPRO) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), APC

4-PAK504Mu01-APC
  • EUR 418.00
  • EUR 4319.00
  • EUR 1173.00
  • EUR 544.00
  • EUR 250.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with APC.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), Biotinylated

4-PAK504Mu01-Biotin
  • EUR 365.00
  • EUR 3225.00
  • EUR 918.00
  • EUR 457.00
  • EUR 242.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with Biotin.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), Cy3

4-PAK504Mu01-Cy3
  • EUR 516.00
  • EUR 5717.00
  • EUR 1523.00
  • EUR 684.00
  • EUR 292.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with Cy3.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), FITC

4-PAK504Mu01-FITC
  • EUR 354.00
  • EUR 3475.00
  • EUR 958.00
  • EUR 455.00
  • EUR 220.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with FITC.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), HRP

4-PAK504Mu01-HRP
  • EUR 379.00
  • EUR 3759.00
  • EUR 1033.00
  • EUR 488.00
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with HRP.

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), PE

4-PAK504Mu01-PE
  • EUR 354.00
  • EUR 3475.00
  • EUR 958.00
  • EUR 455.00
  • EUR 220.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with PE.

Human Calprotectin (CALPRO) Protein

20-abx652257
  • EUR 746.00
  • EUR 300.00
  • EUR 2332.00
  • EUR 885.00
  • EUR 523.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Calprotectin (CALPRO) Polyclonal Antibody (Human)

4-PAK504Hu01
  • EUR 289.00
  • EUR 3170.00
  • EUR 775.00
  • EUR 370.00
  • EUR 232.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu93 and Met1~Pro114 co-expression
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Calprotectin (CALPRO)

Calprotectin (CALPRO) Polyclonal Antibody (Mouse), APC-Cy7

4-PAK504Mu01-APC-Cy7
  • EUR 716.00
  • EUR 8518.00
  • EUR 2227.00
  • EUR 968.00
  • EUR 381.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: Met1~Glu89 and Met1~Lys113
  • Buffer composition: PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Description: A Rabbit polyclonal antibody against Mouse Calprotectin (CALPRO). This antibody is labeled with APC-Cy7.

Leave a Reply

Your email address will not be published. Required fields are marked *